ARCHIVES

Bush Limits Drug Company Efforts To Block Generics

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact

May 21, 1982

Pas Available; Alternative Medicine

January 21, 1994

Low-Income Women Lack Mammography Access: Survey

May 14, 1993

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006